These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17179910)

  • 1. The efficacy of hydrotalcite compared with OTC famotidine in the on-demand treatment of gastroesophageal reflux disease: a non-inferiority trial.
    Konturek JW; Beneke M; Koppermann R; Petersen-Braun M; Weingärtner U
    Med Sci Monit; 2007 Jan; 13(1):CR44-9. PubMed ID: 17179910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
    Holtmeier W; Holtmann G; Caspary WF; Weingärtner U
    J Clin Gastroenterol; 2007 Jul; 41(6):564-70. PubMed ID: 17577112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Symptomatic therapy with famotidine in non-erosive gastro-esophageal reflux. Results of an open multicenter study].
    Heckers H; Lübbecke F
    Arzneimittelforschung; 1995 Apr; 45(4):499-504. PubMed ID: 7779150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy, safety and cost-effectiveness of hydrotalcite versus esomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in China.
    Xiao YL; Nie YQ; Hou XH; Xie PY; Fang JY; Yuan YZ; Zhou LY; Zhao NQ; Chen MH
    J Dig Dis; 2013 Sep; 14(9):463-8. PubMed ID: 23659834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
    J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group.
    Sabesin SM; Berlin RG; Humphries TJ; Bradstreet DC; Walton-Bowen KL; Zaidi S
    Arch Intern Med; 1991 Dec; 151(12):2394-400. PubMed ID: 1746996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind clinical, endoscopic and histological comparison of hydrotalcite/dimethicone suspension and magnesium hydroxide/aluminum hydroxide suspension in the treatment of symptomatic gastritis.
    Cobden I; McMahon MJ; Dixon MF; Axon AT
    Pharmatherapeutica; 1981; 2(9):607-12. PubMed ID: 7267678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of action, efficacy, and onset dynamics of a single dose of alginates in patients with heartburn and GERD].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2009; (4):77-85. PubMed ID: 19960998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
    Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB
    Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
    Richter JE; Long JF
    Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hydrotalcite in the treatment of reflux esophagitis: a multicenter clinical study].
    Hydrotalcid Multicenter Clinical Cooperative Group
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):819-22. PubMed ID: 16206671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal maintenance therapy in patients with non-erosive reflux disease reporting mild reflux symptoms--a pilot study.
    Cibor D; Ciećko-Michalska I; Owczarek D; Szczepanek M
    Adv Med Sci; 2006; 51():336-9. PubMed ID: 17357336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bethanechol versus antiacids in the treatment of gastroesophageal reflux.
    Levi P; Marmo F; Saluzzo C; Dell'Olio D; Ansaldi N; Giuliani L; Guardamagna O; Mostert M; Ponzone A
    Helv Paediatr Acta; 1985 Dec; 40(5):349-59. PubMed ID: 2867985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnesium hydroxide and aluminum hydroxide in the treatment of gastroesophageal reflux].
    Iacono G; Carroccio A; Montalto G; Cavataio F; Ippolito S; Kazmierska I; Balsamo V
    Minerva Pediatr; 1991 Dec; 43(12):797-800. PubMed ID: 1798406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
    Miner PB; Allgood LD; Grender JM
    Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famotidine in gastroesophageal reflux disease (GERD).
    Wesdorp IC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.